- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 27 Reference Ions Near m/z 767.4962
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000007199 Reliable | 767.4875 | 767.4872 ~ 767.4878 MzDiff: 2.4 ppm |
Not Annotated | 7.24 (0%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000008636 Reliable | 767.4983 | 767.4981 ~ 767.4986 MzDiff: 1.8 ppm |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
5.82 (90%) | Rattus norvegicus [UBERON:0004360] cauda epididymis |
MSI_000021245 Reliable | 767.4875 | 767.4872 ~ 767.4878 MzDiff: 2.4 ppm |
Not Annotated | 5.6 (0%) | Rattus norvegicus [UBERON:0004360] cauda epididymis |
MSI_000007438 Reliable | 767.4984 | 767.4981 ~ 767.4986 MzDiff: 1.8 ppm |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
4.54 (89%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000060537 Unreliable | 767.4985 | 767.4984 ~ 767.4988 MzDiff: 1.5 ppm |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
6.37 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
MSI_000061366 Unavailable | 767.4985 | 767.4984 ~ 767.4985 MzDiff: 0.3 ppm |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
-0.42 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000002624 Unreliable | 767.4988 | 767.4988 ~ 767.4988 MzDiff: none |
Ginsenoside Rg6 (BioDeep_00000230608) Formula: C42H70O12 (766.4867) |
0.04 (100%) | Rattus norvegicus [UBERON:0001950] neocortex |
MSI_000003368 Unavailable | 767.4988 | 767.4988 ~ 767.4988 MzDiff: none |
Ginsenoside Rg6 (BioDeep_00000230608) Formula: C42H70O12 (766.4867) |
-0.29 (100%) | Rattus norvegicus [UBERON:0002037] cerebellum |
MSI_000004850 Unreliable | 767.4988 | 767.4988 ~ 767.4988 MzDiff: none |
Ginsenoside Rg6 (BioDeep_00000230608) Formula: C42H70O12 (766.4867) |
1.21 (100%) | Rattus norvegicus [UBERON:0002298] brainstem |
MSI_000005947 Unavailable | 767.4988 | 767.4988 ~ 767.4988 MzDiff: none |
Ginsenoside Rg6 (BioDeep_00000230608) Formula: C42H70O12 (766.4867) |
-1.05 (100%) | Rattus norvegicus [UBERON:0002435] striatum |
MSI_000022799 Unreliable | 767.5003 | 767.5003 ~ 767.5003 MzDiff: none |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
1.04 (100%) | Mus musculus [UBERON:0004250] upper arm bone |
MSI_000026625 Unreliable | 767.4937 | 767.4937 ~ 767.4937 MzDiff: none |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
1.79 (100%) | Mus musculus [UBERON:0002048] lung |
MSI_000026762 Unreliable | 767.5024 | 767.5024 ~ 767.5024 MzDiff: none |
Boc-phepsi(CH(OH)CH2)phe-val-phe-morpholine (BioDeep_00000176787) Formula: C42H56N4O7 (728.4149) |
1.79 (100%) | Mus musculus [UBERON:0002048] lung |
MSI_000027046 Unreliable | 767.4867 | 767.4867 ~ 767.4867 MzDiff: none |
Not Annotated | 1.78 (0%) | Mus musculus [UBERON:0002048] lung |
MSI_000028988 Unreliable | 767.4979 | 767.4979 ~ 767.4979 MzDiff: none |
Not Annotated | 0.07 (0%) | Macropus giganteus [UBERON:0001891] midbrain |
MSI_000029397 Unreliable | 767.4979 | 767.4979 ~ 767.4979 MzDiff: none |
Not Annotated | 1.02 (0%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000029403 Unreliable | 767.4914 | 767.4914 ~ 767.4914 MzDiff: none |
PG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (BioDeep_00000031729) Formula: C42H71O10P (766.4785) |
1 (100%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000029864 Unavailable | 767.5045 | 767.5045 ~ 767.5045 MzDiff: none |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
-0.3 (100%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000030784 Unreliable | 767.5045 | 767.5045 ~ 767.5045 MzDiff: none |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
1 (100%) | Macropus giganteus [UBERON:0003027] cingulate cortex |
MSI_000030842 Unreliable | 767.4979 | 767.4979 ~ 767.4979 MzDiff: none |
Not Annotated | 0.83 (0%) | Macropus giganteus [UBERON:0003027] cingulate cortex |
MSI_000030955 Unreliable | 767.4914 | 767.4914 ~ 767.4914 MzDiff: none |
PG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (BioDeep_00000031729) Formula: C42H71O10P (766.4785) |
0.46 (100%) | Macropus giganteus [UBERON:0003027] cingulate cortex |
MSI_000031170 Unreliable | 767.5045 | 767.5045 ~ 767.5045 MzDiff: none |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
2.15 (100%) | Macropus giganteus [UBERON:0006093] precuneus cortex |
MSI_000031281 Unreliable | 767.4914 | 767.4914 ~ 767.4914 MzDiff: none |
PG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (BioDeep_00000031729) Formula: C42H71O10P (766.4785) |
1.46 (100%) | Macropus giganteus [UBERON:0006093] precuneus cortex |
MSI_000031461 Unreliable | 767.4979 | 767.4979 ~ 767.4979 MzDiff: none |
Not Annotated | 0.68 (0%) | Macropus giganteus [UBERON:0006093] precuneus cortex |
MSI_000044166 Unreliable | 767.4988 | 767.4988 ~ 767.4988 MzDiff: none |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
0.94 (100%) | Rattus norvegicus [UBERON:0002264] olfactory bulb |
MSI_000059190 Unavailable | 767.4988 | 767.4988 ~ 767.4988 MzDiff: none |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
-0.83 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000059578 Unreliable | 767.4988 | 767.4988 ~ 767.4988 MzDiff: none |
(20E)-Ginsenoside F4 (BioDeep_00000017394) Formula: C42H70O12 (766.4867) |
1.11 (100%) | Mus musculus [UBERON:0002298] brainstem |
Found 21 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
Ginsenoside Rg6 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 6.3) |
Rattus norvegicus (Brain) |
Spectroswiss - sol_2x_br_2Resolution: 17μm, 488x193
|
|
m/z_767.4878 Formula: - (n/a) Adducts: (Ppm: 0) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_17Resolution: 17μm, 208x108
1 male adult wild-type rat was obtained from Inserm U1085 - Irset Research Institute (University of Rennes1, France). Animals were age 60 days and were reared under ad-lib conditions. Care and handling of all animals complied with EU directive 2010/63/EU on the protection of animals used for scientific purposes. The whole epididymis was excised from each animal immediately post-mortem, loosely wrapped rapidly in an aluminum foil and a 2.5% (w/v) carboxymethylcellulose (CMC) solution was poured to embed the epididymis to preserve their morphology. To remove air bubbles, the filled aluminum molds was gently freezed by depositing it on isopentane or dry ice, then on the nitrogen vapors and finally by progressively dipping the CMC/sample coated with aluminum foil into liquid nitrogen (or only flush with liquid nitrogen). Frozen tissues were stored at -80 °C until use to avoid degradation. |
|
m/z_767.4877 Formula: - (n/a) Adducts: (Ppm: 0) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_43Resolution: 17μm, 298x106
|
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 6) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_43Resolution: 17μm, 298x106
|
|
m/z_767.4873 Formula: - (n/a) Adducts: (Ppm: 0) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_46Resolution: 17μm, 298x106
|
|
m/z_767.4873 Formula: - (n/a) Adducts: (Ppm: 0) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_47Resolution: 17μm, 301x111
|
|
m/z_767.4875 Formula: - (n/a) Adducts: (Ppm: 0) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito01_04Resolution: 17μm, 178x91
|
|
m/z_767.4875 Formula: - (n/a) Adducts: (Ppm: 0) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito01_06Resolution: 17μm, 183x103
|
|
m/z_767.4875 Formula: - (n/a) Adducts: (Ppm: 0) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_14Resolution: 17μm, 205x103
|
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 5.9) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_14Resolution: 17μm, 205x103
|
|
m/z_767.4945 Formula: - (n/a) Adducts: (Ppm: 0) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 8.1) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 8.2) |
Mus musculus (Left upper arm) |
357_l_total ion countResolution: 50μm, 97x131
Diseased |
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 3.3) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 0.4) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 2.5) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 2.9) |
Mus musculus (Lung) |
image2Resolution: 40μm, 550x256
Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b)
[PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9-
choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in
parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in
white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar
regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids
PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using
total ion current normalisation and hotspot removal (high quantile = 99%). |
|
m/z_767.4979 Formula: - (n/a) Adducts: (Ppm: 0) |
Macropus giganteus (Brain) |
170321_kangaroobrain-dan3-pos_maxof50.0_med1Resolution: 50μm, 81x50
Sample information
Organism: Macropus giganteus (kangaroo)
Organism part: Brain
Condition: Wildtype
Sample growth conditions: Wild |
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 5.4) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 6) |
Mus musculus (brain) |
Brain02_Bregma-3-88Resolution: 17μm, 288x282
|
|
(20E)-Ginsenoside F4 Formula: C42H70O12 (766.4867) Adducts: [M+H]+ (Ppm: 5.9) |
Mus musculus (brain) |
Brain02_Bregma-1-46Resolution: 17μm, 294x399
|
|